Board of Scientific Counselors, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/ATSDR), 23979-23980 [2014-09702]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 82 / Tuesday, April 29, 2014 / Notices
appointed as public members of federal
advisory committees. Individuals
appointed to serve as public members of
federal advisory committees are
classified as special government
employees (SGEs). SGEs are government
employees for purposes of the conflict
of interest laws. Therefore, individuals
appointed to serve as public members of
NVAC are subject to an ethics review.
The ethics review is conducted to
determine if the individual has any
interests and/or activities in the private
sector that may conflict with
performance of their official duties as a
member of the NVAC. Individuals
appointed to serve as public members of
the NVAC will be required to disclose
information regarding financial
holdings, consultancies, research grants
and/or contracts, and the absence of an
appearance of a loss of impartiality.
Dated: April 22, 2014.
Bruce Gellin,
Deputy Assistant Secretary for Health,
Director, National Vaccine Program Office,
Executive Secretary, National Vaccine
Advisory Committee.
[FR Doc. 2014–09634 Filed 4–28–14; 8:45 am]
BILLING CODE 4150–44–P
sroberts on DSK5SPTVN1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Evaluating Promising
Strategies to Build the Evidence Base for
Sexual Violence Prevention, Funding
Opportunity Announcement (FOA)
CE14–005, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 10:30 a.m.–7:30 p.m.
EDT, May 15, 2014 (Closed)
Place: CDC, 4770 Buford Highway,
Conference Room 8C, Atlanta, Georgia
30341
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters For Discussion: The meeting
will include the initial review,
discussion, and evaluation of
16:56 Apr 28, 2014
[FR Doc. 2014–09703 Filed 4–28–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
Centers for Disease Control and
Prevention
Jkt 232001
Review Officer, CDC, 4770 Buford
Highway, NE., Mailstop F63, Atlanta,
Georgia 30341, Telephone: (770) 488–
0641.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Gary J. Johnson,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2014–09701 Filed 4–28–14; 8:45 am]
BILLING CODE 4163–18–P
Gary J. Johnson,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Mar<15>2010
applications received in response to
‘‘Evaluating Promising Strategies to
Build the Evidence Base for Sexual
Violence Prevention, FOA CE14–005.’’
Contact Person For More Information:
Donald Blackman, Ph.D., Scientific
Review Officer, CDC, 4770 Buford
Highway NE., Mailstop F63, Atlanta,
Georgia 30341, Telephone: (770) 488–
0641.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
23979
The meeting announced below
concerns Research Grants for Preventing
Violence and Violence Related Injury,
Funding Opportunity Announcement
(FOA) CE14–006, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 10:30 a.m.–5:30 p.m.
EDT, May 29–30, 2014 (Closed)
Place: CDC, 4770 Buford Highway,
Conference Rooms 8C and 8A, Atlanta,
Georgia 30341
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters For Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Research Grants for Preventing
Violence and Violence Related Injury,
FOA CE14–006.’’
Contact Person For More Information:
Donald Blackman, Ph.D., Scientific
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry (BSC, NCEH/
ATSDR)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates: 9:15 a.m.–4:15 p.m.,
May 22, 2014; 8:30 a.m.–12:30 p.m.,
May 23, 2014.
Place: CDC, 4770 Buford Highway,
Atlanta, Georgia 30341.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 60
people.
Purpose: The Secretary, Department
of Health and Human Services (HHS)
and by delegation, the Director, CDC
and Administrator, NCEH/ATSDR, are
authorized under Section 301 (42 U.S.C.
241) and Section 311 (42 U.S.C. 243) of
the Public Health Service Act, as
amended, to: (1) Conduct, encourage,
cooperate with, and assist other
appropriate public authorities, scientific
institutions, and scientists in the
conduct of research, investigations,
experiments, demonstrations, and
studies relating to the causes, diagnosis,
treatment, control, and prevention of
physical and mental diseases and other
impairments; (2) assist states and their
political subdivisions in the prevention
of infectious diseases and other
preventable conditions and in the
promotion of health and well being; and
E:\FR\FM\29APN1.SGM
29APN1
23980
Federal Register / Vol. 79, No. 82 / Tuesday, April 29, 2014 / Notices
(3) train state and local personnel in
health work. The BSC, NCEH/ATSDR
provides advice and guidance to the
Secretary, HHS; the Director, CDC and
Administrator, ATSDR; and the
Director, NCEH/ATSDR, regarding
program goals, objectives, strategies, and
priorities in fulfillment of the agency’s
mission to protect and promote people’s
health. The board provides advice and
guidance that will assist NCEH/ATSDR
in ensuring scientific quality,
timeliness, utility, and dissemination of
results. The board also provides
guidance to help NCEH/ATSDR work
more efficiently and effectively with its
various constituents and to fulfill its
mission in protecting America’s health.
Matters for Discussion: The agenda
items for the BSC Meeting will include
NCEH/ATSDR Office of the Director
updates; CDC Winnable Battles: Food
Safety; consideration of a subcommittee
to the BSC for childhood lead poisoning
prevention; vote on recommendation
regarding a subcommittee to the BSC for
childhood lead poisoning prevention;
radiation preparedness planning;
NCEH/ATSDR Strategic Planning and
Priorities; NCEH/ATSDR Priority: Water
Safety; updates from the National
Institute for Environmental Health
Services, National Institute for
Occupational Safety and Health, U.S.
Department of Energy and the U.S.
Environmental Protection Agency;
NCEH/ATSDR Response to Prior BSC
Guidance; discussion of future BSC
agenda topics and action items.
Agenda items are subject to change as
priorities dictate.
The
public comment period is scheduled on
Thursday, May 22, 2014 from 3:00 p.m.
until 3:15 p.m., and on Friday, May 23,
2014 from 10:45 a.m. until 11:00 a.m.
Contact Person for More Information:
Sandra Malcom, Committee
Management Specialist, NCEH/ATSDR,
4770 Buford Highway, Mail Stop F–61,
Chamblee, Georgia 30345; Telephone
770/488–0575 or 770/488–0755, Fax:
770/488–3377; Email: smalcom@
cdc.gov. The deadline for notification of
attendance is May 16, 2014.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
sroberts on DSK5SPTVN1PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Mar<15>2010
16:56 Apr 28, 2014
Jkt 232001
Prevention and the Agency for Toxic
Substances and Disease Registry.
Gary J. Johnson,
Acting Director, Management Analysis and
Services Office Centers for Disease Control
and Prevention.
[FR Doc. 2014–09702 Filed 4–28–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–0487]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Generic Clearance
for the Collection of Qualitative
Feedback on Agency Service Delivery
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the Agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal Agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
the collection of information involving
a generic clearance for qualitative
feedback on Agency service delivery.
DATES: Submit either electronic or
written comments on the collection of
information by June 30, 2014.
ADDRESSES: Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT: FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 1350 Piccard
Dr., PI50–400B, Rockville, MD 20850,
PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
SUMMARY:
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
Generic Clearance for the Collection of
Qualitative Feedback on Agency
Service Delivery (OMB Control Number
0697)—Extension
The information collection activity
will garner qualitative customer and
stakeholder feedback in an efficient,
timely manner, in accordance with the
Administration’s commitment to
improving service delivery. By
qualitative feedback we mean
information that provides useful
insights on perceptions and opinions,
but are not statistical surveys that yield
quantitative results that can be
generalized to the population of study.
This feedback will provide insights into
customer or stakeholder perceptions;
experiences and expectations; provide
an early warning of issues with service;
or focus attention on areas where
communication, training, or changes in
operations might improve delivery of
products or services. These collections
will allow for ongoing collaborative and
actionable communications between the
Agency and its customers and
stakeholders. It will also allow feedback
E:\FR\FM\29APN1.SGM
29APN1
]]>Agencies
[Federal Register Volume 79, Number 82 (Tuesday, April 29, 2014)]
[Notices]
[Pages 23979-23980]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-09702]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Environmental
Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/
ATSDR)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Times and Dates: 9:15 a.m.-4:15 p.m., May 22, 2014; 8:30 a.m.-12:30
p.m., May 23, 2014.
Place: CDC, 4770 Buford Highway, Atlanta, Georgia 30341.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 60 people.
Purpose: The Secretary, Department of Health and Human Services
(HHS) and by delegation, the Director, CDC and Administrator, NCEH/
ATSDR, are authorized under Section 301 (42 U.S.C. 241) and Section 311
(42 U.S.C. 243) of the Public Health Service Act, as amended, to: (1)
Conduct, encourage, cooperate with, and assist other appropriate public
authorities, scientific institutions, and scientists in the conduct of
research, investigations, experiments, demonstrations, and studies
relating to the causes, diagnosis, treatment, control, and prevention
of physical and mental diseases and other impairments; (2) assist
states and their political subdivisions in the prevention of infectious
diseases and other preventable conditions and in the promotion of
health and well being; and
[[Page 23980]]
(3) train state and local personnel in health work. The BSC, NCEH/ATSDR
provides advice and guidance to the Secretary, HHS; the Director, CDC
and Administrator, ATSDR; and the Director, NCEH/ATSDR, regarding
program goals, objectives, strategies, and priorities in fulfillment of
the agency's mission to protect and promote people's health. The board
provides advice and guidance that will assist NCEH/ATSDR in ensuring
scientific quality, timeliness, utility, and dissemination of results.
The board also provides guidance to help NCEH/ATSDR work more
efficiently and effectively with its various constituents and to
fulfill its mission in protecting America's health.
Matters for Discussion: The agenda items for the BSC Meeting will
include NCEH/ATSDR Office of the Director updates; CDC Winnable
Battles: Food Safety; consideration of a subcommittee to the BSC for
childhood lead poisoning prevention; vote on recommendation regarding a
subcommittee to the BSC for childhood lead poisoning prevention;
radiation preparedness planning; NCEH/ATSDR Strategic Planning and
Priorities; NCEH/ATSDR Priority: Water Safety; updates from the
National Institute for Environmental Health Services, National
Institute for Occupational Safety and Health, U.S. Department of Energy
and the U.S. Environmental Protection Agency; NCEH/ATSDR Response to
Prior BSC Guidance; discussion of future BSC agenda topics and action
items.
Agenda items are subject to change as priorities dictate.
SUPPLEMENTARY INFORMATION: The public comment period is scheduled on
Thursday, May 22, 2014 from 3:00 p.m. until 3:15 p.m., and on Friday,
May 23, 2014 from 10:45 a.m. until 11:00 a.m.
Contact Person for More Information: Sandra Malcom, Committee
Management Specialist, NCEH/ATSDR, 4770 Buford Highway, Mail Stop F-61,
Chamblee, Georgia 30345; Telephone 770/488-0575 or 770/488-0755, Fax:
770/488-3377; Email: smalcom@cdc.gov. The deadline for notification of
attendance is May 16, 2014.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the Centers for Disease Control and Prevention and the Agency for
Toxic Substances and Disease Registry.
Gary J. Johnson,
Acting Director, Management Analysis and Services Office Centers for
Disease Control and Prevention.
[FR Doc. 2014-09702 Filed 4-28-14; 8:45 am]
BILLING CODE 4163-18-P
